[Clinical studies on application of Visken in treatment of coronary disease (author's transl)]. 1973

L Ziólkowski, and K Ilmurzyńska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Ziólkowski, and K Ilmurzyńska
July 1977, MMW, Munchener medizinische Wochenschrift,
L Ziólkowski, and K Ilmurzyńska
January 1975, Rinsho byori. The Japanese journal of clinical pathology,
L Ziólkowski, and K Ilmurzyńska
July 1981, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
L Ziólkowski, and K Ilmurzyńska
September 1976, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
L Ziólkowski, and K Ilmurzyńska
April 1979, Nippon Ganka Gakkai zasshi,
L Ziólkowski, and K Ilmurzyńska
January 1974, Przeglad lekarski,
L Ziólkowski, and K Ilmurzyńska
October 1975, Sbornik lekarsky,
L Ziólkowski, and K Ilmurzyńska
November 1976, Medizinische Klinik,
L Ziólkowski, and K Ilmurzyńska
November 1975, Langenbecks Archiv fur Chirurgie,
Copied contents to your clipboard!